Showing 2241-2250 of 9355 results for "".
- Rubedo Plans Clinical Trial of RLS-1496 for Androgenetic Alopeciahttps://practicaldermatology.com/news/rubedo-plans-clinical-trial-of-rls-1496-for-androgenetic-alopecia/2488446/Rubedo Life Sciences announced plans to evaluate its investigational GPX4 modulator RLS-1496 in patients with androgenetic alopecia (AGA), following ex vivo findings showing increased growth of human hair follicles exposed to the agent, according to an a
- FDA Grants Priority Review to Zasocitinib for Plaque Psoriasishttps://practicaldermatology.com/news/fda-grants-priority-review-to-zasocitinib-for-plaque-psoriasis/2488421/The US Food and Drug Administration (FDA) has accepted Takeda’s new drug application (NDA) for zasocitinib (TAK-279) for adults with moderate-to-severe plaque psoriasis and granted the application Priority Review, according to a company announcement.
- PISCES: Adalimumab Biosimilar Achieves PASI75 in 81% of Children With Severe Psoriasishttps://practicaldermatology.com/news/pisces-adalimumab-biosimilar-achieves-pasi75-in-81-of-children-with-severe-psoriasis/2488405/The first prospective study of an adalimumab biosimilar in Chinese children with severe plaque psoriasis showed significant clinical response through 16 weeks and no reported adverse events. The multicenter PISCES study, published in Dermatology and Therapy, included 80 patients a
- PCA SKIN Launches Acne Control Prebiotic Gel Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-acne-control-prebiotic-gel-cleanser/2488391/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a daily cleanser designed for acne-prone skin that pairs acne-fighting ingredients with technology intended to support the skin microbiome. The gel-to-lather cleanser contains 2% salicylic acid to help clear and prevent acne breako
- Consensus Statement: JAK Inhibitors Emerge as Primary Therapy for Severe Alopeciahttps://practicaldermatology.com/news/consensus-statement-jak-inhibitors-emerge-as-primary-therapy-for-severe-alopecia/2488332/A US expert consensus provides a standardized treatment framework for adults with severe alopecia areata (AA), placing oral Janus kinase (JAK) inhibitors at the center of long-term disease management.
- Review Integrates Functional and Aesthetic BTX-A Treatment for Facial Paralysishttps://practicaldermatology.com/news/review-integrates-functional-and-aesthetic-btx-a-treatment-for-facial-paralysis/2488325/Botulinum toxin A (BTX-A) may offer dermatologists a way to address the functional, therapeutic, and aesthetic manifestations of facial paralysis within a single treatment framework, a recent review suggested.d BTX-A Targets Multiple Sequelae of Facial Paralysis The authors conduc
- Daily SPF Use Lags Among Youth: Surveyhttps://practicaldermatology.com/news/daily-spf-use-lags-among-youth-in-multigenerational-skincare-survey/2488298/Interest in facial skincare is growing among children and adolescents, new findings suggest. Researchers evaluated a 3-product regimen consisting of a hydrating cream cleanser, hydrating moisturizer, and daily mineral SPF 40
- Upadacitinib Shows Sustained Responses in PsA After Prior TNF Inhibitor: Analysishttps://practicaldermatology.com/news/upadacitinib-shows-sustained-responses-in-psa-after-prior-tnf-inhibitor-analysis/2488287/A post hoc analysis of SELECT-PsA 2 found sustained responses with upadacitinib 15 mg once daily through 152 weeks among patients with psoriatic arthritis (PsA) previously exposed to 1 tumor necrosis factor inhibitor (TNFi). Published in RMD Open, the analysis included 195 patient
- Outpatient Dermatology Care Linked to Fewer HS Hospital Readmissions: Analysishttps://practicaldermatology.com/news/outpatient-dermatology-care-linked-to-fewer-hs-hospital-readmissions-analysis/2488266/Hidradenitis suppurativa (HS) carries a significant acute-care burden, but outpatient dermatology follow-up may be associated with fewer hospital readmissions, according to a study published in Archives of Dermatological Research
- GLP-1 Weight Loss Not Linked to Higher Body-Contouring Surgery Complication Rateshttps://practicaldermatology.com/news/glp-1-weight-loss-not-linked-to-higher-body-contouring-surgery-complication-rates/2488256/The method patients used to lose weight—including injectable glucagon-like peptide-1 (GLP-1) receptor agonist pharmacotherapy—was not associated with differences in postoperative complication rates after body-contouring surgery, according to a retrospective study p